• Awareness Of Hepatitis B Virus Reactivation Among Physicians Administering Immunosuppressive Treatment And Related Clinical Practices 

      Korkmaz, Pinar; Demirturk, Nese; Aydin, Gule; Ceken, Sabahat; Aygen, Bilgehan; Toka, Onur; Gundogdu, Kiymet; Kocagul-Celikbas, Aysel; Inan, Dilara; Kuruuzum, Ziya; Eren-Kutsoylu, Oya Ozlem; Batirel, Ayse; Sirmatel, Fatma; Ersoz, Gulden; Hakyemez, Ismail Necati; Asci, Zerrin; Yesilbag, Zuhal; Sonmezer, Meliha Cagla; Tulek, Necla; Ormen, Bahar; Yilmaz-Karadag, Fatma; Yoruk, Gulsen; Turker, Nesrin; Ozkaya, Hacer Deniz; Akdemir-Kalkan, Irem; Suer, Huseyin Kaya; Tekin, Suda; Saltoglu, Nese; Sener, Alper; Yenilmez, Ercan; Cetinkaya, Riza Aytac; Arslan-Ozeln, Selcan; Ayaz, Celal; Karagoz, Ergenekon; Aydinn, Mehtap; Acar, Ali; Arslan, Eyup; Ceylan, Mehmet Resat; Aktug-Demir, Nazlim; Dirgen-Caylak, Selmin; Gunal, Ozgur; Haykir-Solay, Asli; Ozturk, Sinan; Ural, Onur; Sumer, Sua; Kadanali, Ayten; Gunes-Altiparmak, Vuslat Ecem; Akhan, Sila; Sayan, Murat; Kose, Sukran (2019)
      Objective: This study aimed to evaluate the awareness and knowledge levels of all physicians administering immunosuppressive treatment concerning hepatitis B virus (HBV) reactivation, and draw attention to the importance ...
    • Effect Of Hepatosteatosis On The Virological Response In Entecavir And Tenofovir Therapies 

      Korkmaz, Pinar; Demirturk, Nese; Batirel, Ayse; Tulek, Necla; Ozguler, Muge; Harman, Rezan; Cinar, Gule; Toka, Onur; Yoruk, Gulsen; Ataman-Hatipoglu, Cigdem; Sarigul, Figen; Sirmatel, Fatma; Imre, Ayfer; Mistanoglu-Ozatag, Duru; Karakecili, Faruk; Ural, Onur; Sumer, Sua; Aktug-Demir, Nazlim; Kadanali, Ayten; Comoglu, Senol; Ucer, Sengul; Saltoglu, Nese; Gunal, Ozgur; Ozkaya, Hacer Deniz; Yenilmez, Ercan; Cetinkaya, Riza Aytac; Yuksel, Esma; Hakyemez, Ismail Necati; Meric-Koc, Meliha; Tuncer-Ertem, Gunay; Bestepe-Dursun, Zehra; Celik, Ilhami; Yilmaz, Emel; Evik, Guliz; Kaya, Ali; Suer, Kaya (2019)
      Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine ...